CA2793683A1 - Peptidomimetiques pour moduler le recepteur d'interleukine-1 - Google Patents

Peptidomimetiques pour moduler le recepteur d'interleukine-1 Download PDF

Info

Publication number
CA2793683A1
CA2793683A1 CA2793683A CA2793683A CA2793683A1 CA 2793683 A1 CA2793683 A1 CA 2793683A1 CA 2793683 A CA2793683 A CA 2793683A CA 2793683 A CA2793683 A CA 2793683A CA 2793683 A1 CA2793683 A1 CA 2793683A1
Authority
CA
Canada
Prior art keywords
peptide
peptidomimetic
seq
amino acids
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2793683A
Other languages
English (en)
Inventor
Sylvain Chemtob
Christiane Quiniou
William D. Lubell
Stephane Turcotte
Nicolas Boutard
Luisa Ronga
Andrew Jamieson
Daniel St-Cyr
Wang Chen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CENTRE HOSPITALIER UNIVERSITAIRE SAINTE-JUSTINE
Universite de Montreal
Original Assignee
CENTRE HOSPITALIER UNIVERSITAIRE SAINTE-JUSTINE
Universite de Montreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CENTRE HOSPITALIER UNIVERSITAIRE SAINTE-JUSTINE, Universite de Montreal filed Critical CENTRE HOSPITALIER UNIVERSITAIRE SAINTE-JUSTINE
Publication of CA2793683A1 publication Critical patent/CA2793683A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA2793683A 2009-03-20 2010-03-19 Peptidomimetiques pour moduler le recepteur d'interleukine-1 Abandoned CA2793683A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16207009P 2009-03-20 2009-03-20
US61/162,070 2009-03-20
PCT/IB2010/000914 WO2010106441A2 (fr) 2009-03-20 2010-03-19 Peptidomimétiques pour moduler le récepteur d'interleukine-1

Publications (1)

Publication Number Publication Date
CA2793683A1 true CA2793683A1 (fr) 2010-09-23

Family

ID=42740062

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2793683A Abandoned CA2793683A1 (fr) 2009-03-20 2010-03-19 Peptidomimetiques pour moduler le recepteur d'interleukine-1

Country Status (2)

Country Link
CA (1) CA2793683A1 (fr)
WO (1) WO2010106441A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202404574A (zh) * 2022-06-15 2024-02-01 美商默沙東有限責任公司 用於捕捉介白素-1 β之環狀肽

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6706916B1 (en) * 1999-02-23 2004-03-16 Toray Fine Chemicals Co., Ltd. Optically active amino acid derivatives and processes for the preparation of the same
BRPI0507971A (pt) * 2004-02-23 2007-07-24 Tufts College composto, composição farmacêutica, uso de um composto,método para inibir a atividade proteolìtica de uma enzima de clivagem pós-prolina e remédio empacotado
WO2005105830A1 (fr) * 2004-05-05 2005-11-10 Valorisation-Recherche, Societe En Commandite Antagonistes du recepteur de l'interleukine-1, compositions, et methodes de traitement
WO2007004060A2 (fr) * 2005-05-05 2007-01-11 Valorisation Hsj, Societe En Commandite Modulateurs du recepteur de la cytokine et leurs utilisations

Also Published As

Publication number Publication date
WO2010106441A2 (fr) 2010-09-23
WO2010106441A3 (fr) 2010-11-18

Similar Documents

Publication Publication Date Title
US8618054B2 (en) Interleukin-1 receptor antagonists, compositions, and methods of treatment
US9994616B2 (en) c-Met protein agonist
AU2010321240B2 (en) Template-fixed peptidomimetics with CCR10 antagonistic activty
WO2015030014A1 (fr) Peptide macrocyclique, son procédé de production, et procédé de criblage à l'aide d'une bibliothèque de peptides macrocycliques
CA2607113C (fr) Antagonistes du recepteur de l'interleukine-1, compositions, et methodes de traitement
CN111447941B (zh) 用于细胞内递送装订肽的多肽缀合物
Tang et al. Synthesis of cyclopentapeptides and cycloheptapeptides by DEPBT and the influence of some factors on cyclization
CN114573674A (zh) 一种α9α10 nAChR抑制活性肽及其应用
EP2764010B9 (fr) Peptidomimetiques fixes sur matrice, utilises comme inhibiteurs du fpr1
CN115298194A (zh) Vipr2拮抗肽
US11162083B2 (en) Peptide based inhibitors of Raf kinase protein dimerization and kinase activity
US20230303647A1 (en) Cyclic chemerin-9 derivatives
CA2793683A1 (fr) Peptidomimetiques pour moduler le recepteur d'interleukine-1
Pawar et al. Linear and cyclic glycopeptide as HIV protease inhibitors
JP6952320B2 (ja) 新規ｎｋ３受容体アゴニスト
Wong et al. A comparison of pseudoproline substitution effects on cyclisation yield in the total syntheses of segetalins B and G
EP4063380A1 (fr) Inhibiteurs de la voie de signalisation par wnt et leurs utilisations
CA3240982A1 (fr) Inhibiteurs peptidiques du recepteur de l'interleukine-23
Murray cHYD1 solution phase synthesis optimization and the development of a novel human growth hormone antagonist and agonist
Nguyen Expanding the Scope of mRNA display by Chemical Approaches
Beauregard Degree M. Sc.--Université de Montréal, 2012.
Beauregard Développement de peptidomimétiques antagonistes du récepteur de l’interleukine-1β
CN115698032A (zh) 困难序列的高效的肽缩合法
Aillard Small molecule mimics of trans-proline: synthesis and applications
Varese Approaches to the synthesis of cyclic peptides with inhibitory activity

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20150313

FZDE Dead

Effective date: 20170718